LINC01214 Promotes Non‐Small Cell Lung Cancer Through the miR‐497‐3p/HSP90AB1 Axis
Canadian Respiratory Journal · 2025
DOI: 10.1155/carj/5575392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Respiratory Journal, 2025. Verfasst von Guangfu Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, MicroRNAs, Lung Neoplasms, HSP90 Heat-Shock Proteins. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to explore the potential of LINC01214 in providing prognostic and therapeutic insights, thereby offering valuable references for the research of non‐small cell lung cancer (NSCLC).
Methods
122 NSCLC subjects were recruited. The molecular level was quantified by qPCR and WB. Kaplan–Meier estimated the prognostic effects and Cox regression analyses the hazard ratio. The cell activities including proliferation, apoptosis, and migration/invasion were evaluated by CCK‐8, flow cytometry, and Transwell. The regulatory axis of LINC01214/miR‐497‐3p/HSP90AB1 was verified by the dual luciferase reporter assay and rescue experiments.
Results
LINC01214 increased both in the malignant tissues and cell lines of NSCLC. Mortality was increased in NSCLC patients with high LINC01214 levels. LINC01214 was an independent risk predictor of prognosis in NSCLC. Silencing of LINC01214 inhibited the NSCLC cell proliferation, migration, and invasion and promoted apoptosis. The abundance of miR‐497‐3p showed an opposite trend to LINC01214. LINC01214 could target miR‐497‐3p and negatively correlate with miR‐497‐3p. The inhibitory effect of LINC01214 on cell activity was reversed by miR‐497‐3p. HSP90AB1 was predicted and further confirmed as the target of miR‐497‐3p. The LINC01214/miR‐497‐3p/HSP90AB1 axis regulated NSCLC cell proliferation, migration, and invasion.
Conclusion
LINC01214, a potential biomarker, contributed to the progression of NSCLC through the miR‐497‐3p/HSP90AB1 axis by promoting cell proliferation and motility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China.
- Department of Pulmonary and Critical Care Medicine, The People's Hospital of Dadukou District Chongqing, Chongqing 400084, China.
- Department of Medical Imaging, Dongying People's Hospital, Dongying 257091, China.
- Department of Respiratory and Critical Care Medicine, First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
ORCID-Profile: Fei Li, Jiangtao Cao
Zitieren
APA
Xu, G., Zhang, L., Li, F., Han, W., Sun, H., & Cao, J. (2025). LINC01214 Promotes Non‐Small Cell Lung Cancer Through the miR‐497‐3p/HSP90AB1 Axis. Canadian Respiratory Journal. https://doi.org/10.1155/carj/5575392
Vancouver
Xu G, Zhang L, Li F, Han W, Sun H, Cao J. LINC01214 Promotes Non‐Small Cell Lung Cancer Through the miR‐497‐3p/HSP90AB1 Axis. Canadian Respiratory Journal. 2025. doi:10.1155/carj/5575392
BibTeX
@article{Xu2025,
author = {Xu, Guangfu and Zhang, Ling and Li, Fei and Han, Wenwen and Sun, Hailong and Cao, Jiangtao},
title = {LINC01214 Promotes Non‐Small Cell Lung Cancer Through the miR‐497‐3p/HSP90AB1 Axis},
journal = {Canadian Respiratory Journal},
year = {2025},
doi = {10.1155/carj/5575392}
}
EUVIMED